BP
The startup operates a biopharmaceutical platform focused on developing bispecific antibodies that can penetrate the blood-brain barrier. This technology aims to create effective treatments for neurological diseases such as brain tumors, Alzheimer's, and Parkinson's, addressing significant gaps in current medical therapies.
Updated 2 months ago
Funding
$20M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup operates a biopharmaceutical platform focused on developing bispecific antibodies that can penetrate the blood-brain barrier. This technology aims to create effective treatments for neurological diseases such as brain tumors, Alzheimer's, and Parkinson's, addressing significant gaps in current medical therapies.